A University of Cambridge cancer research laboratory which uses imaging technologies to measure key biologic changes within growing tumours has announced a three-year oncology research collaboration with Medimmune.
Two teams of University of Cambridge students have won a prestigious international competition to commercialise innovative breast cancer research.
A new therapy for peanut allergy has been successful in the majority of the 99 children who took part in a clinical trial.
‘Smart’ holograms, which are currently being tested to monitor diabetes, and could be used to monitor a wide range of medical and environmental conditions in future, have been developed by researchers.
Approval concludes nearly 40-year epic journey from fundamental research to discovery of an effective treatment for active relapsing multiple sclerosis
A new technology under development by an academic–industry partnership protects oral vaccines from destruction by the digestive system.
A range of diseases and conditions, from asthma to liver disease, could be diagnosed and monitored quickly and painlessly just by breathing, using gas sensing technology developed by a Cambridge spin-out.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.
© 2025 University of Cambridge